Methods Patients and definitions Starting in March 2022, patients with IIH and BMI 30 kg/m 2 were routinely offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM) consisting of dietary counselling and non-supervised physical exercise per treatment algorithm at the interdisciplinary IIH center at the Medical University of Vienna
If reactions persist or worsen, discontinue use and consult a dermatologist
Regulators must show that the recall reaches every pharmacy, clinic and patient who may hold the product
Steer toward unflavored or terpene-only formulas
Most users report needing 30 to 90 days before noticing significant effects, though some experience reduced appetite and cravings within the first two to four weeks
When brand-name Mounjaro costs exceed one thousand dollars monthly and peptide therapy costs for compounded versions become less favorable, switching to a more affordable option becomes necessary